Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 6 | 2026 | 866 | 1.130 |
Why?
|
| Heart | 2 | 2021 | 650 | 0.950 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.740 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 52 | 0.620 |
Why?
|
| Heart Failure | 5 | 2025 | 2287 | 0.620 |
Why?
|
| Heart, Artificial | 1 | 2019 | 63 | 0.600 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 108 | 0.580 |
Why?
|
| Pulmonary Veins | 1 | 2020 | 168 | 0.570 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 77 | 0.570 |
Why?
|
| Atrial Function, Left | 1 | 2018 | 32 | 0.570 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 165 | 0.550 |
Why?
|
| Heart Diseases | 2 | 2020 | 490 | 0.530 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 451 | 0.520 |
Why?
|
| Palliative Care | 1 | 2021 | 441 | 0.520 |
Why?
|
| Heart Atria | 1 | 2018 | 325 | 0.480 |
Why?
|
| Echocardiography | 1 | 2019 | 1113 | 0.400 |
Why?
|
| Child | 18 | 2026 | 25081 | 0.380 |
Why?
|
| Hypertension | 1 | 2019 | 1301 | 0.340 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 494 | 0.290 |
Why?
|
| Infant | 8 | 2025 | 12760 | 0.250 |
Why?
|
| Graft Rejection | 3 | 2026 | 553 | 0.230 |
Why?
|
| Psychotropic Drugs | 1 | 2026 | 122 | 0.220 |
Why?
|
| Pandemics | 3 | 2023 | 1134 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 93 | 0.220 |
Why?
|
| Transplant Recipients | 1 | 2026 | 230 | 0.210 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2024 | 39 | 0.210 |
Why?
|
| Humans | 21 | 2026 | 126679 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2025 | 16985 | 0.200 |
Why?
|
| Pericarditis | 1 | 2023 | 44 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 288 | 0.190 |
Why?
|
| Pericardial Effusion | 1 | 2023 | 71 | 0.190 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 175 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.180 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 121 | 0.170 |
Why?
|
| Pediatrics | 2 | 2020 | 1198 | 0.170 |
Why?
|
| Adolescent | 8 | 2026 | 19987 | 0.170 |
Why?
|
| Young Adult | 4 | 2024 | 9655 | 0.160 |
Why?
|
| Cardiologists | 1 | 2020 | 25 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 718 | 0.160 |
Why?
|
| Remote Consultation | 1 | 2020 | 24 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 172 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 526 | 0.160 |
Why?
|
| Biopsy | 1 | 2023 | 1236 | 0.160 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 42 | 0.150 |
Why?
|
| Child, Preschool | 7 | 2026 | 14336 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 200 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 629 | 0.150 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2019 | 73 | 0.150 |
Why?
|
| Physician's Role | 1 | 2020 | 159 | 0.150 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 36 | 0.140 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 370 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 560 | 0.140 |
Why?
|
| Inflammation | 1 | 2025 | 1420 | 0.140 |
Why?
|
| Observer Variation | 1 | 2018 | 305 | 0.130 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 253 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2022 | 1194 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 228 | 0.130 |
Why?
|
| Heart-Assist Devices | 1 | 2025 | 1045 | 0.120 |
Why?
|
| Phenotype | 2 | 2024 | 4302 | 0.120 |
Why?
|
| Adult | 5 | 2024 | 30379 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
|
| Cardiology | 1 | 2020 | 486 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 515 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2026 | 5113 | 0.110 |
Why?
|
| Stents | 1 | 2020 | 769 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2018 | 1398 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 488 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2019 | 1312 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2025 | 1847 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2013 | 21 | 0.100 |
Why?
|
| Male | 10 | 2026 | 62490 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2225 | 0.100 |
Why?
|
| Zebrafish | 2 | 2013 | 402 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1102 | 0.090 |
Why?
|
| Age Factors | 1 | 2018 | 2788 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 162 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2882 | 0.090 |
Why?
|
| Habenula | 1 | 2011 | 44 | 0.090 |
Why?
|
| Female | 9 | 2026 | 68275 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 4772 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 968 | 0.070 |
Why?
|
| Neurons | 2 | 2013 | 1919 | 0.060 |
Why?
|
| Hospitalization | 2 | 2024 | 1874 | 0.050 |
Why?
|
| Glycosylation | 1 | 2024 | 111 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1569 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2026 | 231 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2023 | 99 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 28 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 98 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 442 | 0.050 |
Why?
|
| Chest Pain | 1 | 2023 | 124 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 153 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 275 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 225 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 4953 | 0.040 |
Why?
|
| Brain | 1 | 2013 | 3037 | 0.040 |
Why?
|
| Risk Factors | 2 | 2026 | 10545 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2026 | 12537 | 0.040 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 73 | 0.040 |
Why?
|
| Medicine | 1 | 2020 | 100 | 0.040 |
Why?
|
| Graft Survival | 1 | 2021 | 454 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 649 | 0.040 |
Why?
|
| Prevalence | 1 | 2026 | 2591 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1047 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 354 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 476 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 443 | 0.040 |
Why?
|
| Models, Biological | 1 | 2023 | 1370 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 486 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2100 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 765 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 1532 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 967 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6203 | 0.030 |
Why?
|
| Epithalamus | 1 | 2013 | 1 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2969 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 449 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 176 | 0.020 |
Why?
|
| Nodal Signaling Ligands | 1 | 2011 | 1 | 0.020 |
Why?
|
| SEC Translocation Channels | 1 | 2011 | 5 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 307 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 321 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8343 | 0.020 |
Why?
|
| Body Patterning | 1 | 2011 | 128 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 602 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 202 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2011 | 182 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 563 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 206 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 5939 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2756 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11297 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1842 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 20321 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 33045 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4472 | 0.010 |
Why?
|